HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Makoto Otsu Selected Research
Makoto Otsu Research Topics
Disease
9
Neoplasms (Cancer)
01/2017 - 02/2006
5
Severe combined immunodeficiency due to adenosine deaminase deficiency
12/2021 - 02/2002
3
Teratoma (Teratoid Tumor)
01/2015 - 11/2010
2
Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
12/2021 - 08/2002
2
Inflammation (Inflammations)
01/2017 - 11/2013
2
Lysosomal Storage Diseases (Lysosomal Storage Disease)
11/2016 - 05/2014
2
Mucopolysaccharidosis II (Hunter Syndrome)
11/2016 - 03/2015
2
Leukemia
07/2013 - 06/2012
1
Chromosomal Instability (Chromosome Stability)
08/2023
1
Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2023
1
Autoimmune Diseases (Autoimmune Disease)
01/2023
1
Osteoporosis
10/2018
1
Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
10/2018
1
Chronic Granulomatous Disease
10/2016
1
Myeloproliferative Disorders (Myeloproliferative Disorder)
01/2015
1
Liver Diseases (Liver Disease)
12/2014
1
Type C Niemann-Pick Disease (Niemann Pick Disease, Type C)
11/2014
1
Primary Myelofibrosis (Myelosclerosis)
09/2014
1
Glycogen Storage Disease Type II (Pompe's Disease)
05/2014
1
Insulin Resistance
11/2013
1
Bone Marrow Failure Disorders
09/2013
1
Congenital amegakaryocytic thrombocytopenia
09/2013
1
Pancytopenia
09/2013
1
Leukopenia
09/2013
1
Thrombocytopenia (Thrombopenia)
09/2013
1
Anemia
09/2013
1
Graft vs Host Disease (Graft-Versus-Host Disease)
07/2013
1
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
06/2012
1
Thrombosis (Thrombus)
02/2012
1
Fabry Disease (Fabry's Disease)
05/2011
1
Primary Immunodeficiency Diseases
01/2010
1
Vesicular Stomatitis
09/2008
1
X-Linked Combined Immunodeficiency Diseases (X Linked Severe Combined Immunodeficiency)
01/2002
Drug/Important Bio-Agent (IBA)
4
Adenosine Deaminase
IBA
12/2021 - 02/2002
4
Proteins (Proteins, Gene)
FDA Link
07/2011 - 09/2008
2
Glycosaminoglycans
IBA
11/2016 - 03/2015
2
Complementary DNA (cDNA)
IBA
10/2016 - 09/2008
2
Codon (Codons)
IBA
10/2016 - 09/2008
2
Cytokines
IBA
09/2014 - 08/2009
2
Antigens
IBA
07/2011 - 02/2006
1
Chromatin
IBA
08/2023
1
Interferons
IBA
01/2023
1
Diphosphonates (Bisphosphonates)
IBA
10/2018
1
Clodronic Acid (Clodronate)
IBA
10/2018
1
Heparitin Sulfate (Heparan Sulfate)
IBA
11/2016
1
Iduronic Acid (Iduronate)
IBA
11/2016
1
Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)
IBA
01/2015
1
Sphingosine
IBA
11/2014
1
Interleukin-8 (Interleukin 8)
IBA
09/2014
1
Messenger RNA (mRNA)
IBA
09/2014
1
Glycogen
IBA
05/2014
1
Glucosidases
IBA
05/2014
1
Acids
IBA
05/2014
1
Interleukin-10 (Interleukin 10)
IBA
11/2013
1
Cohesins
IBA
10/2013
1
Thrombopoietin Receptors
IBA
09/2013
1
Imatinib Mesylate (Gleevec)
FDA Link
06/2012
1
Talin
IBA
02/2012
1
Integrins
IBA
02/2012
1
Acetylcysteine (Siran)
FDA Link
Generic
02/2012
1
Estrogen Receptors
IBA
07/2011
1
Glycolipids
IBA
05/2011
1
Galactosidases
IBA
05/2011
1
Enzymes
IBA
05/2011
1
Interleukin-2 (IL2)
IBA
04/2009
1
Peptides (Polypeptides)
IBA
02/2006
1
ZAP-70 Protein-Tyrosine Kinase (ZAP 70 Protein Tyrosine Kinase)
IBA
08/2002
Therapy/Procedure
4
Transplantation
01/2017 - 09/2008
4
Therapeutics
12/2014 - 01/2002
3
Bone Marrow Transplantation (Transplantation, Bone Marrow)
11/2016 - 05/2011
2
Immunotherapy
04/2009 - 02/2006
1
Enzyme Replacement Therapy
12/2015
1
Intravenous Injections
07/2013
1
Hematopoietic Stem Cell Transplantation
01/2010
1
Cell- and Tissue-Based Therapy (Cell Therapy)
01/2010